This two-day conference examines the safety, quality, and regulatory issues involved in a wide array of contexts central to the pharmaceutical and biotech industries, including drug packaging and delivery components, single-use systems, medical devices, and parenteral drug products. We will focus closely on the keys to satisfying recent revisions to several applicable USP chapters, FDA guidances & other international regulatory requirements for best practices in materials and chemistry characterization for drugs, biologics, delivery systems, and primary & secondary packaging.

Regulators in North America and Europe are requiring stricter standards for the manufacture and safety testing of combination products in both the Pharma and med device industries. This two-day summit features expert insight into CP product development, and the complex quality, safety, and regulatory compliance issues facing the CP market.